Global Diammonium Glycyrrhizinate Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Diammonium Glycyrrhizinate Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Diammonium Glycyrrhizinate is used in the treatment of acute and chronic viral hepatitis with elevated glutamylaminotransferase. It can improve the symptoms of chronic hepatitis B and restore ALT. It also has certain effect on reducing bilirubin.
Diammonium Glycyrrhizinate report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Diammonium Glycyrrhizinate market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Chronic Viral Hepatitis and Immune Regulation are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Diammonium Glycyrrhizinate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Diammonium Glycyrrhizinate key companies include Sinopharm Guorui Pharmaceutical Co. Ltd, Chia Tai Tianqing Pharmaceutical Group Co. Ltd, Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd, Suzhou Erye Pharmaceutical Co. Ltd, Jiangsu Tiansheng Pharmaceutical Co. Ltd, Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd and ND Pharma & Biotech Co. Ltd., etc. Sinopharm Guorui Pharmaceutical Co. Ltd, Chia Tai Tianqing Pharmaceutical Group Co. Ltd, Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd are top 3 players and held % share in total in 2022.
Diammonium Glycyrrhizinate can be divided into Injection and Capsule, etc. Injection is the mainstream product in the market, accounting for % share globally in 2022.
Diammonium Glycyrrhizinate is widely used in various fields, such as Chronic Viral Hepatitis and Immune Regulation, etc. Chronic Viral Hepatitis provides greatest supports to the Diammonium Glycyrrhizinate industry development. In 2022, global % share of Diammonium Glycyrrhizinate went into Chronic Viral Hepatitis filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Diammonium Glycyrrhizinate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Sinopharm Guorui Pharmaceutical Co. Ltd
Chia Tai Tianqing Pharmaceutical Group Co. Ltd
Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd
Suzhou Erye Pharmaceutical Co. Ltd
Jiangsu Tiansheng Pharmaceutical Co. Ltd
Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd
ND Pharma & Biotech Co. Ltd.
Segment by Type
Injection
Capsule
Chronic Viral Hepatitis
Immune Regulation
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Diammonium Glycyrrhizinate market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Diammonium Glycyrrhizinate introduction, etc. Diammonium Glycyrrhizinate Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Diammonium Glycyrrhizinate market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Diammonium Glycyrrhizinate report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Diammonium Glycyrrhizinate market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Chronic Viral Hepatitis and Immune Regulation are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Diammonium Glycyrrhizinate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Diammonium Glycyrrhizinate key companies include Sinopharm Guorui Pharmaceutical Co. Ltd, Chia Tai Tianqing Pharmaceutical Group Co. Ltd, Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd, Suzhou Erye Pharmaceutical Co. Ltd, Jiangsu Tiansheng Pharmaceutical Co. Ltd, Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd and ND Pharma & Biotech Co. Ltd., etc. Sinopharm Guorui Pharmaceutical Co. Ltd, Chia Tai Tianqing Pharmaceutical Group Co. Ltd, Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd are top 3 players and held % share in total in 2022.
Diammonium Glycyrrhizinate can be divided into Injection and Capsule, etc. Injection is the mainstream product in the market, accounting for % share globally in 2022.
Diammonium Glycyrrhizinate is widely used in various fields, such as Chronic Viral Hepatitis and Immune Regulation, etc. Chronic Viral Hepatitis provides greatest supports to the Diammonium Glycyrrhizinate industry development. In 2022, global % share of Diammonium Glycyrrhizinate went into Chronic Viral Hepatitis filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Diammonium Glycyrrhizinate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Sinopharm Guorui Pharmaceutical Co. Ltd
Chia Tai Tianqing Pharmaceutical Group Co. Ltd
Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd
Suzhou Erye Pharmaceutical Co. Ltd
Jiangsu Tiansheng Pharmaceutical Co. Ltd
Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd
ND Pharma & Biotech Co. Ltd.
Segment by Type
Injection
Capsule
Segment by Application
Chronic Viral Hepatitis
Immune Regulation
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Diammonium Glycyrrhizinate market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Diammonium Glycyrrhizinate introduction, etc. Diammonium Glycyrrhizinate Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Diammonium Glycyrrhizinate market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices